Brazil issues first license for sale of a cannabis-based drug

SAO PAULO, Jan 16 (Reuters) - Brazilian healthcare regulator

Anvisa on Monday said it had issued the country's first license

for sale of a cannabis-based drug in the country after years of

legal wrangling with patients.

Read more